Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Liberman, Julie ^a   Sartelet, Hervé ^b   Flahaut, Marjorie ^a   Mühlethaler Mottet, Annick ^a   Coulon, Aurélie ^a,d   Nyalendo, Carine ^b   Vassal, Gilles ^c   Joseph, Jean Marc ^a   Gross, Nicole ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF MONTREAL   (Canada)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Swissnex San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CHEMOTAXIS; CHILD; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; METASTASIS; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR CELL LINE; TUMOR DIFFERENTIATION; TUMOR GROWTH;

CELL MOVEMENT; CHEMOKINE CXCL12; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; NEUROBLASTOMA; PHOSPHORYLATION; RECEPTORS, CXCR; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS;

EID: 84865160647     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043665     Document Type: Article

References (69)

1. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA, ((1989)) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49:: 219--225.
2. Brodeur GM, ((2003)) Neuroblastoma: biological insights into a clinical enigma. NatRevCancer 3:: 203--216.
3. Thelen M, ((2001)) Dancing to the tune of chemokines. NatImmunol 2:: 129--134.
4. Baggiolini M, Dewald B, Moser B, ((1997)) Human chemokines: an update. AnnuRevImmunol 15:: 675--705.
5. Rot A, von Andrian UH, ((2004)) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. AnnuRevImmunol 22:: 891--928.
6. Vicari AP, Caux C, ((2002)) Chemokines in cancer. Cytokine Growth Factor Rev 13:: 143--154.
7. Balkwill F, ((2003)) Chemokine biology in cancer. SeminImmunol 15:: 49--55.
8. Somasundaram R, Herlyn D (2008) Chemokines and the microenvironment in neuroectodermal tumor-host interaction. Semin Cancer Biol.
9. Balkwill F, ((2004)) The significance of cancer cell expression of the chemokine receptor CXCR4. SeminCancer Biol 14:: 171--179.
10. Sun X, Cheng G, Hao M, Zheng J, Zhou X, et al. ((2010)) CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev 29:: 709--722.
11. Muller A, Homey B, Soto H, Ge N, Catron D, et al. ((2001)) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:: 50--56.
12. Wang J, Sun Y, Song W, Nor JE, Wang CY, et al. ((2005)) Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell Signal 17:: 1578--1592.
13. Zeelenberg IS, Ruuls-Van Stalle L, Roos E, ((2003)) The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63:: 3833--3839.
14. Airoldi I, Raffaghello L, Piovan E, Cocco C, Carlini B, et al. ((2006)) CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications. ClinCancer Res 12:: 77--82.
15. Arscott WT, LaBauve AE, May V, Wesley UV, ((2009)) Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation. Oncogene 28:: 479--491.
16. Meier R, Muhlethaler-Mottet A, Flahaut M, Coulon A, Fusco C, et al. ((2007)) The Chemokine Receptor CXCR4 Strongly Promotes Neuroblastoma Primary Tumour and Metastatic Growth, but not Invasion. PLoSONE 2:: e1016.
17. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, et al. ((2006)) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. JExpMed 203:: 2201--2213.
18. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, et al. ((2005)) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. JBiolChem 280:: 35760--35766.
19. Mazzinghi B, Ronconi E, Lazzeri E, Sagrinati C, Ballerini L, et al. ((2008)) Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. JExpMed 205:: 479--490.
20. Thelen M, Thelen S, ((2008)) CXCR7, CXCR4 and CXCL12: an eccentric trio? J Neuroimmunol 198:: 9--13.
21. Odemis V, Lipfert J, Kraft R, Hajek P, Abraham G, et al. (2011) The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells. Glia.
22. Hartmann TN, Grabovsky V, Pasvolsky R, Shulman Z, Buss EC, et al. (2008) A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. JLeukocBiol.
23. Odemis V, Boosmann K, Heinen A, Kury P, Engele J, ((2010)) CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J Cell Sci 123:: 1081--1088.
24. Wang J, Shiozawa Y, Wang Y, Jung Y, Pienta KJ, et al. ((2008)) The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. JBiolChem 283:: 4283--4294.
25. Tiveron MC, Boutin C, Daou P, Moepps B, Cremer H, ((2010)) Expression and function of CXCR7 in the mouse forebrain. J Neuroimmunol 224:: 72--79.
26. Schonemeier B, Kolodziej A, Schulz S, Jacobs S, Hoellt V, et al. ((2008)) Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J Comp Neurol 510:: 207--220.
27. Gerrits H, van Ingen Schenau DS, Bakker NE, van Disseldorp AJ, Strik A, et al. ((2008)) Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice. Genesis 46:: 235--245.
28. Yu S, Crawford D, Tsuchihashi T, Behrens TW, Srivastava D, ((2011)) The chemokine receptor CXCR7 functions to regulate cardiac valve remodeling. Dev Dyn 240:: 384--393.
29. Sierro F, Biben C, Martinez-Munoz L, Mellado M, Ransohoff RM, et al. ((2007)) Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A 104:: 14759--14764.
30. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, et al. ((2007)) CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. ProcNatlAcadSciUSA 104:: 15735--15740.
31. Kollmar O, Rupertus K, Scheuer C, Nickels RM, Haberl GC, et al. ((2010)) CXCR4 and CXCR7 regulate angiogenesis and CT26.WT tumor growth independent from SDF-1. Int J Cancer 126:: 1302--1315.
32. Luker KE, Lewin SA, Mihalko LA, Schmidt BT, Winkler JS, et al. (2012) Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Oncogene.
33. Hernandez L, Magalhaes MA, Coniglio SJ, Condeelis JS, Segall JE, ((2011)) Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Res 13:: R128.
34. Thiele CJ (1999) Neuroblastoma. Human Cell Culture. 21-53.
35. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW, ((1979)) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:: 16--23.
36. Li JK, Yu L, Shen Y, Zhou LS, Wang YC, et al. ((2008)) Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol 14:: 2308--2313.
37. Joseph JM, Gross N, Lassau N, Rouffiac V, Opolon P, et al. ((2005)) In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts. IntJCancer 113:: 881--890.
38. Gross N, Beck D, Favre S, Carrel S, ((1987)) In vitro antigenic modulation of human neuroblastoma cells induced by IFN-gamma, retinoic acid and dibutyryl cyclic AMP. IntJCancer 39:: 521--529.
39. de TC, Beleta H, Diaz R, Toran N, Rodriguez E, et al. ((2009)) The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors. Cancer 115:: 2792--2803.
40. Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T, ((1984)) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14:: 135--144.
41. Hamburger AW, Salmon SE, ((1977)) Primary bioassay of human tumor stem cells. Science 197:: 461--463.
42. Ross RA, Spengler BA, Rettig WJ, Biedler JL, ((1994)) Differentiation-inducing agents stably convert human neuroblastoma I-type cells to neuroblastic (N) or nonneuronal (S) neural crest cells. Prog Clin Biol Res 385:: 253--259.
43. Sugimoto T, Kato T, Sawada T, Horii Y, Kemshead JT, et al. ((1988)) Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine. Cancer Res 48:: 2531--2537.
44. Acosta S, Lavarino C, Paris R, Garcia I, de TC, et al. ((2009)) Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells. BMC Dev Biol 9:: 12.
45. Hattermann K, Held-Feindt J, Lucius R, Muerkoster SS, Penfold ME, et al. ((2010)) The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 70:: 3299--3308.
46. Grymula K, Tarnowski M, Wysoczynski M, Drukala J, Barr FG, et al. ((2010)) Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas. Int J Cancer 127:: 2554--2568.
47. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF, ((2008)) The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. CurrCancer Drug Targets 8:: 187--198.
48. Xu H, Wu Q, Dang S, Jin M, Xu J, et al. ((2011)) Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma. PLoS ONE 6:: e27399.
49. Monnier J, Boissan M, L'helgoualc'h A, Lacombe ML, Turlin B, et al. (2011) CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur J Cancer.
50. Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, et al. ((2005)) CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65:: 465--472.
51. Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, et al. ((2005)) Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 65:: 5864--5871.
52. Russell HV, Hicks J, Okcu MF, Nuchtern JG, ((2004)) CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. JPediatrSurg 39:: 1506--1511.
53. Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ, et al. ((1995)) Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ 6:: 449--456.
54. Infantino S, Moepps B, Thelen M, ((2006)) Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. JImmunol 176:: 2197--2207.
55. Ma M, Ye JY, Deng R, Dee CM, Chan GC (2011) Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling. Cancer Lett.
56. Decaillot FM, Kazmi MA, Lin Y, Ray-Saha S, Sakmar TP, et al. (2011) CXCR7/CXCR4 heterodimer constitutively recruits {beta}-arrestin to enhance cell migration. J Biol Chem.
57. Singh RK, Lokeshwar BL, ((2011)) The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth. Cancer Res 71:: 3268--3277.
58. Luker KE, Steele JM, Mihalko LA, Ray P, Luker GD, ((2010)) Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 29:: 4599--4610.
59. Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, et al. ((2008)) Control of chemokine-guided cell migration by ligand sequestration. Cell 132:: 463--473.
60. Valentin G, Haas P, Gilmour D, ((2007)) The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b. CurrBiol 17:: 1026--1031.
61. Dambly-Chaudiere C, Cubedo N, Ghysen A, ((2007)) Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMCDevBiol 7:: 23.
62. Zabel BA, Lewen S, Berahovich RD, Jaen JC, Schall TJ, ((2011)) The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells. Mol Cancer 10:: 73.
63. Hawkins OE, Richmond A, ((2012)) The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Res 14:: 103.
64. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B, ((2009)) CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113:: 6085--6093.
65. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Fernandez S, Martin de AA, et al. ((2001)) Chemokine receptor homo-or heterodimerization activates distinct signaling pathways. EMBO J 20:: 2497--2507.
66. Thelen M, Munoz LM, Rodriguez-Frade JM, Mellado M, ((2010)) Chemokine receptor oligomerization: functional considerations. Curr Opin Pharmacol 10:: 38--43.
67. Breitwieser GE, ((2004)) G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling. Circ Res 94:: 17--27.
68. Muhlethaler-Mottet A, Flahaut M, Balmas BK, Auderset K, Meier R, et al. ((2006)) Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro-to anti-apoptotic proteins ratio. BMCCancer 6:: 214.
69. Kim B, van Golen CM, Feldman EL, ((2004)) Insulin-like growth factor-I signaling in human neuroblastoma cells. Oncogene 23:: 130--141.